Research Summary
Analyzed using Evidence Intelligence™

Telemedicine lifestyle intervention modestly improves glycemic control in diabetes

Key finding

Mean between-group difference in the complete-case analysis was -0.13% (95% CI, -0.25 to -0.01), P = 0.04.

A home-based lifestyle intervention with telemedicine support showed modest effects on HbA1c levels in patients with coronary heart disease and type 2 diabetes.

Evidence strength

Moderate confidence

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Some Concerns bias
Last updated July 6, 2026

Quick read

Study at a glance

The essential study design details in one scan.

Population

Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes

Intervention

Home-based telemedicine-supported lifestyle intervention

Study type

RCTs

Follow-up

Long-Term (1–5 y)

Primary outcome

Glycated hemoglobin (HbA1c)

Comparator

Usual Care

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

A home-based lifestyle intervention with telemedicine support showed modest effects on HbA1c levels in patients with coronary heart disease and type 2 diabetes.

Clinical relevance

Improving glycemic control is crucial for patients with CHD and T2DM, as it may reduce the risk of complications. While the intervention showed a modest effect on HbA1c, the lack of significant impact on cardiovascular events highlights the need for comprehensive strategies in managing these patients.

Keep in mind

The study had a modest sample size, which may limit the generalizability of the findings. The intervention's long-term effects beyond 12 months were not assessed. The statistical significance of some outcomes was not achieved, indicating uncertainty in effectiveness.

Published in

Journal Reference

Publication details and source links for this paper.

Stephan M, Sophia MTD, Felix G, et al. A home-based lifestyle intervention with telemedicine support showed modest effects in patients with CHD and T2DM. Nature Medicine. 2025;31(4):1203-1213. doi:10.1038/s41591-025-03498-w

Save this study and add notes to your research library.

Main Effects

The lifestyle intervention reduced HbA1c by -0.13% (95% CI, -0.25 to -0.01), P = 0.04.

At 12 months, 31 patients (6.2%) experienced a major adverse cardiovascular event; P = 0.15.

Hospitalizations for angina or revascularization were higher in the lifestyle intervention group (n = 15) compared to usual care (n = 8).

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Lifestyle intervention for prediabetes and Composite cardiovascular events (CV death, MI, stroke, HF hospitalization), Deaths, HbA1c, and 2 more.

Primary intervention

Lifestyle intervention for prediabetes

Primary outcomes

  • Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)
  • Deaths
  • HbA1c

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

5
Evidence pairs
5
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 68

2

Related topics

5

Evidence pairs

194

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 5 evidence relationships
  • Includes primary outcome data
  • Linked to 2 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Core evidence

Study findings

The primary outcomes reported in this study.

NoneNo Change

Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)

Lifestyle intervention for prediabetes → Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)

Lifestyle intervention for prediabetes → Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)

Evidence profile

NoneNo ChangeClinical Outcomes
Unlock full evidence details
NoneNo Change

Deaths

Lifestyle intervention for prediabetes → Deaths

Lifestyle intervention for prediabetes → Deaths

Evidence profile

NoneNo ChangeSafety
Unlock full evidence details
StrongDecrease

HbA1c

Lifestyle intervention for prediabetes → HbA1c

Lifestyle intervention for prediabetes → HbA1c

Evidence profile

StrongDecreaseGlycemic Control
Unlock full evidence details
NoneNo Change

Hospitalizations

Lifestyle intervention for prediabetes → Hospitalizations

Lifestyle intervention for prediabetes → Hospitalizations

Evidence profile

NoneNo ChangeClinical Outcomes
Unlock full evidence details
NoneNo Change

Hospitalizations for angina or revascularization

Lifestyle intervention for prediabetes → Hospitalizations for angina or revascularization

Lifestyle intervention for prediabetes → Hospitalizations for angina or revascularization

Evidence profile

NoneNo ChangeClinical Outcomes
Unlock full evidence details

Unlock full evidence analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

evidence suggest

Evidence Suggest

  • HbA1c levels decreased by -0.13% with the intervention (P = 0.04).
  • No significant difference in composite cardiovascular events (P = 0.15).
  • More hospitalizations for angina in the intervention group (n = 15) compared to usual care (n = 8).
who this applies

Who this applies to

  • Adults diagnosed with coronary heart disease.
  • Patients with type 2 diabetes mellitus.
  • Individuals seeking lifestyle interventions to manage their health.
keep in mind

Keep in Mind

  • The modest improvement in HbA1c may not translate into significant clinical benefits.
  • Findings may not be applicable to populations outside the study's demographic.
  • Further research is needed to explore long-term outcomes and effectiveness.
between the lines

Between the Lines

  • The study had a modest sample size, which may limit the generalizability of the findings.
  • The intervention's long-term effects beyond 12 months were not assessed.
  • The statistical significance of some outcomes was not achieved, indicating uncertainty in effectiveness.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Lifestyle intervention for prediabetes and HbA1c.

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Lifestyle intervention for prediabetes improve HbA1c?

Emerging Evidence

Lifestyle intervention for prediabetes appears to improve HbA1c.

ConsensusScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Emerging | EvidenceScore™ 58.4 | strong positive | ConsensusScore™ Consistent | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Lifestyle intervention for prediabetes improve composite cardiovascular events (cv death, mi, stroke, hf hospitalization)?

Limited Evidence

Current evidence does not show a clear benefit of Lifestyle intervention for prediabetes for Composite cardiovascular events (CV death, MI, stroke, HF hospitalization).

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Composite cardiovascular events (CV death, MI, stroke, HF hospitalization)

    EvidenceScore™ Limited | EvidenceScore™ 35.4 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Lifestyle intervention for prediabetes improve deaths?

Limited Evidence

Current evidence does not show a clear benefit of Lifestyle intervention for prediabetes for Deaths.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Deaths

    EvidenceScore™ Limited | EvidenceScore™ 35.4 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Lifestyle intervention for prediabetes improve hospitalizations?

Limited Evidence

Current evidence does not show a clear benefit of Lifestyle intervention for prediabetes for Hospitalizations.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Hospitalizations

    EvidenceScore™ Limited | EvidenceScore™ 35.4 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.